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INTRODUCTION

RESULTS

Normohormonal hyperparathyroidism (NHPHP) is a subset of primary
hyperparathyroidism where patients present with normal PTH levels
despite elevated serum calcium1,2,3. This disease variant creates clinical
challenges regarding intraoperative PTH (IOPTH) monitoring during
parathyroidectomy. NHPHP patients are more likely to have
multiglandular disease and smaller sized adenomas, making it more
difficult to reliably localize the adenomas using pre-operative imaging2.
This more often leads to bilateral neck exploration to successfully identify
and remove all hyperactive glands.

Of the 497 patients, 496 were included in the study. There were 66 patients
(13.3%) in the NHPHP group based on preoperative intact PTH (Group 1) and
430 patients in the control group based on patients who demonstrated classic
PHP based on preoperative intact PTH. There were 28 patients (5.6%) in
NHPHP group based on baseline IOPTH on the day of surgery (Group 2) and
467 patients in the control group based on patients who demonstrated classic
PHP based on baseline IOPTH. Patient information regarding age, gender,
BMI, and pre-operative laboratory values can be found in Tables 1 and 2.

Furthermore, reliance on IOPTH decay proves challenging since
preoperative IOPTH is already in the normal range of 14-72 pg/ml.
Traditionally, intraoperative success has been defined as as decline in
IOPTH levels ³50% from the baseline pre-operative level. This study
aimed to determine what percent reduction in post-excision IOPTH from
baseline would yield a cure rate in NHPHP patients similar to that of
classic primary hyperparathyroidism (PHP).

Table 1: Demographic data for the NHPHP group based on preoperative
intact PTH compared to its control group.

METHODS
This was a single institution retrospective cohort study of 497 patients that
underwent parathyroidectomy for primary hyperparathyroidism between
July 2013 and February 2020. Information collected via chart review
included patient demographic information, symptoms, prior neck surgeries,
pre-, intra-, and post-operative laboratory values, and pathology reports.
NHPHP was subdivided into two treatment groups based on 1) diagnosis of
NHPHP based on preoperative intact PTH in the normal range and 2)
diagnosis of NHPHP based on pre-incision IOPTH in the normal range.
The respective control groups were based on patients with classic PHP.
Cure rates and percent decline in IOPTH from baseline were compared
between groups. Cure was defined as intact PTH and calcium levels in the
normal range ³ 6 months after the time of surgery.

Figure 1: Timeline of typical parathyroidectomy patient.
Continuous variables in the data set were not normally distributed, thus,
medians and their interquartile ranges were used. Two-sample Wilcoxon
test and Chi-squared test were used to analyze the differences between the
various groups.

Table 3: Cure rates in NH subgroups compared to their control groups.
Table 4 shows the median percent decline in post-excision IOPTH from
baseline that achieved cure in Group 1 was 82.8% compared to its control
at 87.3%, p = 0.017. In Group 2, the percent drop was 80.4% compared to
its control at 87.1%, p = 0.001. These findings were statistically significant
for both NHPHP subgroups compared to their respective controls.

Table 4: Percent drop in IOPTH in NH subgroups and their control groups.

CONCLUSIONS
Table 2: Demographic data for the NHPHP group based on pre-incision
IOPTH compared to its control group.

The traditional ³50% decline in 15-minute post-excision IOPTH from
baseline may still be adequate in achieving reasonable rate of cure in NHPHP
patients. However, a ³75% decline provides a more stringent criterion for
achieving high rates of cure in NHPHP parathyroidectomy patients for
surgeons who prefer stricter criterion.
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